menu
FR | EN
Digital Healthcare Community
Certified Medical Tourism ProfessionalBest Medical Travel Agency 2015Best use of technology in Medical Travel 2017Certified Temos

Blood thinners associated with improved outcomes for COVID-19 patients - study

07/05/2020

Blood thinners associated with improved outcomes for COVID-19 patients - study

With more evidence emerging that COVID-19 can cause dangerous blood clots in some patients, new research shows that blood thinners could help improve survival rates.


According to the study by a team from Mount Sinai Hospital in New York City, which looked at nearly 2,800 COVID-19 patients admitted to five hospitals across the Mount Sinai Health System, blood thinners were seen to have a positive impact on patient outcomes.


The blood thinners were found to be especially helpful for patients who were put on ventilators to help them breathe. The study found that 63% of patients on ventilators who were not given blood thinners died, compared to 23% of patients on ventilators who were given blood thinners.


Furthermore, of the patients who died, those who were given anticoagulants did so after spending an average of 21 days in the hospital. In contrasts, those who didn't receive anticoagulants died after an average of just 14 days in the hospital.


Finally, the study also revealed that patients who were given blood thinners were not significantly more likely to develop bleeding problems -- one of the risks of taking such drugs.


Speaking about the findings of the research, study senior author Dr. Valentin Fuster, director of Mount Sinai Heart and physician-in-chief at the Mount Sinai Hospital, said: “Using anticoagulants should be considered when patients get admitted to the ER and have tested positive for COVID-19, to possibly improve outcomes.”


[Related reading: World leaders pledge billions to help develop coronavirus vaccine]

expand_less